Literature DB >> 2887104

Multiple islet cell tumors with predominance of glucagon-producing cells and ulcer disease.

C Bordi, O De Vita, F P Pilato, G Carfagna, T D'Adda, G Missale, A Peracchia.   

Abstract

Two cases of multiple islet cell tumors mostly composed of glucagon-producing cells and associated with severe ulcer disease are presented. Multiple endocrine neoplasia type I (MEN-I) was present in both patients, although symptomatically latent in case 2. Immunohistochemistry showed that glucagon (A) cells were a major cell population (i.e., accounting for at least 30% of the tumor cell population) in 24 of 43 tumors (either macroadenomas or microadenomas) studied in case 1 and in 12 of 17 tumors studied in case 2. A major pancreatic polypeptide (PP) cell population was found in 12 and 7 tumors of case 1 and 2, respectively. In contrast, insulin (B) and somatostatin (D) cells were scarce in most adenomas. Gastrin-producing cells were not identified in any tumors, despite the use of different antigastrin antisera. Extrapancreatic or residual gastrinomas were not found at postmortem examination in case 1 or on appropriate surgical inspection done 24 years after the onset of the ulcer disease in patient 2. On the basis of these and of 17 additional cases collected in the literature, it is concluded that multiple A-cell tumors of the pancreas are an expression of the MEN-I and are mostly associated with ulcer disease and/or with hypergastrinemia of frequent uncertain origin. The mechanisms regulating the nonrandom phenotypic hormonal differentiation of these genetically determined tumors remain unknown.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2887104     DOI: 10.1093/ajcp/88.2.153

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  7 in total

1.  Histopathology, hormone products, and clinicopathological profile of endocrine tumors of the upper small intestine: A study of 44 cases.

Authors:  Carlo Capella; Cristina Riva; Guido Rindi; Fausto Sessa; Luciana Usellini; Annamaria Chiaravalli; Luciano Carnevali; Enrico Solcia
Journal:  Endocr Pathol       Date:  1991-06       Impact factor: 3.943

2.  Immunohistochemical localization of factor X-like antigen in pancreatic islets and their tumours.

Authors:  C Bordi; J Y Yu; A Girolami; C Betterle
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

3.  Immunocytochemical patterns of islet cell tumors as defined by the monoclonal antibody HISL-19.

Authors:  C Bordi; K Krisch; G Horvat; S Srikanta
Journal:  Am J Pathol       Date:  1988-08       Impact factor: 4.307

4.  Comparative study of seven neuroendocrine markers in pancreatic endocrine tumours.

Authors:  C Bordi; F P Pilato; T D'Adda
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

5.  Lack of allelic loss at the multiple endocrine neoplasia type 1 (MEN-1) gene locus in a pancreatic ductal (non-endocrine) adenocarcinoma of a patient with the MEN-1 syndrome.

Authors:  C Bordi; A Falchetti; C Azzoni; T D'Adda; A Morelli; A Peracchia; M L Brandi
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

6.  Studies on co-localization of 7B2 and pancreatic hormones in normal and tumoural islet cells.

Authors:  C Azzoni; J Y Yu; M T Baggi; T D'Adda; C Timson; J M Polak; C Bordi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

Review 7.  Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors.

Authors:  Günter Klöppel; Guido Rindi; Martin Anlauf; Aurel Perren; Paul Komminoth
Journal:  Virchows Arch       Date:  2007-08-08       Impact factor: 4.064

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.